- Home
- BLDP vs ESPR Comparison
BLDP vs ESPR Comparison
Compare BLDP & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDP
- ESPR
- Stock Information
- Founded
- BLDP 1979
- ESPR 2008
- Country
- BLDP Canada
- ESPR United States
- Employees
- BLDP N/A
- ESPR N/A
- Industry
- BLDP Industrial Machinery/Components
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- BLDP Energy
- ESPR Health Care
- Exchange
- BLDP Nasdaq
- ESPR Nasdaq
- Market Cap
- BLDP 488.0M
- ESPR 410.2M
- IPO Year
- BLDP 1995
- ESPR 2013
- Fundamental
- Price
- BLDP $1.52
- ESPR $2.15
- Analyst Decision
- BLDP Hold
- ESPR Buy
- Analyst Count
- BLDP 11
- ESPR 5
- Target Price
- BLDP $2.25
- ESPR $5.13
- AVG Volume (30 Days)
- BLDP 9.9M
- ESPR 4.4M
- Earning Date
- BLDP 03-10-2025
- ESPR 02-25-2025
- Dividend Yield
- BLDP N/A
- ESPR N/A
- EPS Growth
- BLDP N/A
- ESPR N/A
- EPS
- BLDP N/A
- ESPR N/A
- Revenue
- BLDP $91,962,000.00
- ESPR $295,451,000.00
- Revenue This Year
- BLDP N/A
- ESPR $186.04
- Revenue Next Year
- BLDP $26.95
- ESPR $11.25
- P/E Ratio
- BLDP N/A
- ESPR N/A
- Revenue Growth
- BLDP 24.01
- ESPR 187.12
- 52 Week Low
- BLDP $1.23
- ESPR $1.58
- 52 Week High
- BLDP $3.66
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- BLDP 41.19
- ESPR 42.65
- Support Level
- BLDP $1.55
- ESPR $2.05
- Resistance Level
- BLDP $1.68
- ESPR $2.31
- Average True Range (ATR)
- BLDP 0.13
- ESPR 0.14
- MACD
- BLDP -0.04
- ESPR 0.01
- Stochastic Oscillator
- BLDP 1.75
- ESPR 28.57
About BLDP Ballard Power Systems Inc.
Ballard Power Systems Inc is a world leader in proton-exchange membrane fuel cells, power system development, and commercialization. The company's principal business is the design, development, manufacture, sale, and service of PEM fuel cell products for a variety of applications, focusing on power product markets of heavy-duty motive (bus, truck, rail, and marine applications), material handling, and stationary power generation. Sales are concentrated in the US, Europe, and China.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.